Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 19, 2021
Poor compliance with an antibiotic directive-A call for intensified monitoringFrederik Novak, Jens T Hørlück, Jacob D Redder, et al.Frontiers in Immunology|September 20, 2024
Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients-a longitudinal cohort studyFrederik Novak, Anna Christine Nilsson, Emil Birch Christensen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Extended interval dosing with ocrelizumab in multiple sclerosisFrederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard, et al.Multiple Sclerosis and Related Disorders|March 25, 2022
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patientsHamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.Multiple Sclerosis and Related Disorders|September 27, 2021
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosisFrederik Novak, Anna Christine Nilsson, Christian Nielsen, et al.Brain Communications|July 7, 2025
Deep learning to predict progression independent of relapse activity at a first demyelinating eventLlucia Coll, Deborah Pareto, Francisco Aparicio-Serrano, et al.Pageof 1